2022
Title: ABO Incompatibility between the Mother and Fetus Does Not Protect against Anti-Human Platelet Antigen-1a Immunization
by Pregnancy.
Laila Miserre, Sandra Wienzek-Lischka, Andreas Mann, Nina Cooper, Sentot Santoso, Harald Ehrhardt, Ulrich J. Sachs and Gregor Bien.
DOI: 10.3390/jcm11226811
Title: Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?
Julia Alm, Yalin Duong, Sandra Wienzek-Lischka, Nina Cooper, Sentot Santoso, Ulrich J Sachs, Volker Kiefel, Gregor Bein.
PMID: 35383895DOI: 10.1111/bjh.18173 Corrections update https://onlinelibrary.wiley.com/doi/10.1111/bjh.18999
Title: Regulation of Platelet Production and Life Span: Role of Bcl-xL and Potential Implications for Human Platelet Diseases.
Emma C. Josefsson, William Vainchenker and Chloe James. https://doi.org/10.3390%2Fijms21207591
Title: Simultaneous genotyping for human platelet antigen systems and HLA-A and HLA-B loci by targeted next-generation sequencing.
Jielin Wang, Xuan You, Yanmin He, Xiaozhen Hong, Ji He, Sudan Tao, and Faming Zhu.
doi: 10.3389/fimmu.2022.945994. PMID: 36263028; PMCID: PMC9575554.
Title: Fetal and neonatal alloimmune thrombocytopenia
National Organization for Rare Disorders | NORD USA
Title: Protecting the fetus from FNAIT.
John W. Semple, Rick Kapur. Blood (2022) 140 (20): 2097–2099.
November 17 2022https://doi.org/10.1182/blood.2022017937
Title: Prophylactic administration of HPA-1a–specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice.
Huiying Zhi, Douglas Sheridan, Debra K. Newman and Peter J. Newman.
Blood Transfusion medicine 17 NOVEMBER 2022 | VOLUME 140, NUMBER 20
Title: Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study
Authors: Thijs W de Vos, MD, Dian Winkelhorst, MD, Valgerdur Árnadóttir, MD, Prof Johanna G van der Bom, MD, Carme Canals Surís, MD, Camila Caram-Deelder, PhD, et al.
Published: The Lancet, September 12, 2022. DOI:https://doi.org/10.1016/S2352-3026(22)00243-5
Title: An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study.
Christof Geisen, Mette Kjaer, Erika Fleck, Bjorn Skogen, Roisín Armstrong, Frank Behrens, Zubin Bhagwagar, Susanne Braeuninger, Anette Mortberg, Klaus Juel Olsen, Stephan Martin Gasten Schäfer, Carmen Walter, Erhard Seifried, Agneta Wikman, Jens Kjeldsen-Kragh, Michaela Koehm.
https://doi.org/10.1016/j.jtha.2022.11.041
Title: Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia.
Authors: T.W. de Vos, M. de Haas, D. Oepkes, R.N.G.B. Tan, C.E. van der Schoot, S.J.Steggerda, L.S. de Vries, E. Lopriore, J.M.M. van Klink Leiden University Medical Center, Leiden, the Netherlands. Published June 2022 https://doi.org/10.1016/j.ajog.2022.05.063
Title: Subamniotic haemorrhage, a possible new presentation of fetal and neonatal alloimmune thrombocytopenia
Authors: Giesbers S, Bos M, Bulten J, van der Meeren L, van Drongelen J
ISSN: 1015–3837 (Print), eISSN: 1421–9964 (Online) https://www.karger.com/FDT Fetal Diagnosis and Therapy
Title: Buffy-coat-derived megakaryocytes for monoclonal antibody immobilization of platelet antigens (MAIMA) assay [abstract].
Authors: Uzun G, Lucic J, Althaus K, Rigoni F, Lyshy F, Nowak-Harnau S, Marini I, Sachs U, Backchoul T.
ISTH2022 Congress, London. 9-13 July www.ISTH.org
Title: Mapping hemorrhagic stroke in the fetal and neonatal period as a consequence of thrombocytopenia. [abstract].
Authors: Farley A, Lloyd s, Dayton M, Biben C, Stonehouse O, Terreaux A, Taoudi S.
www.ISTH.org
Title: Series Review of Fetal/neonatal Alloimmune Thrombocytopenia Diagnosis, Management and Outcome in a Tertiary Care Centre [abstract].
Authors: Santos C, Costa L, Leão D, Graça O, Monteiro F, Correia F, Koch C.
www.ISTH.org
Title: Noninvasive Prenatal Testing in Immunohematology – Clinical, Technical and ethical Considerations.
Jens Kjeldsen-Kragh1,2,* and Åsa Hellberg1
1 Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, SE-221 85 Lund, Sweden
2 Department of Laboratory Medicine, University Hospital of North Norway, N-9019 Tromsø, Norway
* Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(10), 2877; https://doi.org/10.3390/jcm11102877
Title: Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospect cohort study.
Thijs W de Vos, MD Dian Winkelhorst, MD Valgerdur Árnadóttir, MD Prof Johanna G van der Bom, MD Carme Canals Surís, MD Camila Caram-Deelder, PhD et al. Published:The Lancet, September 12, 2022DOI: https://doi.org/10.1016/S2352-3026(22)00243-5
Title: Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
Authors. Thijs L J Van Osch, Janita J Oosterhoff, Arthur E H Bentlage, Jan Nouta, Carolien A M Koeleman, Dionne M Geerdes, Juk Yee Mok, Sebastiaan Heidt, Arend Mulder, Wim J E Van Esch, Rick Kapur, Leendert Porcelijn, C Ellen Van der Schoot, Masja De Haas, Manfred Wuhrer, Jan Voorberg, Gestur Vidarsson.
Title: Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies Ernstsen SL et al. – 2022
Siw L. Ernstsen, MD; Maria T. Ahlen, PhD; Tiril Johansen, MD; Eirin L. Bertelsen, MSc; Jens Kjeldsen-Kragh, PhD; Heidi Tiller, PhD
